 |
 |
 |
My most pressing patient was a 28-year-old woman who had recurrent ovarian cancer and was actually near death's door at the time of a surgery for an intestinal blockage.
READ MORE » |
|
She has had an amazing recovery in the last three months and is now eating and almost ready for discharge home to her 7-year-old daughter and her husband who eagerly await her return.
READ MORE » |
|
Precision is committed to high-integrity research into the development of individualized cancer treatment support tools and services. Click here for more information on our clinical trials program.
READ MORE » |
|
|
|
 |
|
Precision's Quarterly Newsletter
July 2008
READ MORE »
Precision announces study results: ChemoFx correlates with outcomes in breast cancer
Sean McDonald named Entrepreneur of the Year winner
20, 2008
Precision announces study results at ASCO: ChemoFx correlates with survival in ovarian cancer
READ MORE
Precision's Quarterly Newsletter
April 2008
READ MORE »
Precision Adds 8 Million Covered Lives Under Contract
Precision announces study results with independent cytopathologist
READ MORE
|
 |
|
A significant body of research exists supporting the science and technology behind ChemoFx and exploring other issues related to individualized chemotherapy treatments. We've compiled much of it, including works by Precision Therapeutics researchers, in our Bibliography & Publications section.REVIEW THE RESEARCH » |
|
